Wesley Self Archives
Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization
Mar. 2, 2021—As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.
Convalescent plasma improved survival in COVID-19 patients with blood cancers
Feb. 5, 2021—Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Nov. 9, 2020—Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.
Self named VP for Clinical Research Networks and Strategy
Oct. 29, 2020—Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.
Clinical trial to test HIV drugs to treat COVID-19
Oct. 16, 2020—Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
Treating appendicitis with antibiotics instead of surgery may be good option for some, but not all, patients
Oct. 5, 2020—Antibiotics instead of surgery may be a good choice for some, but not all, patients with appendicitis, according to results from a study reported today in the New England Journal of Medicine.
Study finds COVID-19 antibodies drop substantially in the weeks following infection
Sep. 17, 2020—The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).
Study shows eating at restaurants may increase COVID-19 risk
Sep. 11, 2020—Eating at dine-in restaurants appears to increase the risk of becoming sick with COVID-19, according to a recent study by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University Medical Center.
COVID infections in health workers often go undetected: study
Sep. 3, 2020—Many COVID-19 infections among health care workers go undetected, likely because many people infected with SARS-CoV-2, the virus that causes COVID-19, have mild or no symptoms, a study led by Vanderbilt University Medical Center’s Wesley Self, MD, MPH, shows.
VUMC awarded $34 million to lead nationwide convalescent plasma study
Aug. 21, 2020—Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients
Jul. 16, 2020—Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.
About half of health care workers positive for COVID-19 by serology have no symptoms
Jul. 9, 2020—The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.